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Pro-survival signalling from the NMDA receptor
Giles. E. Hardingham
Abstract
Ca2+ influx through the NMDA subtype of ionotropic glutamate receptors plays a Jekyll and Hyde
role in the mammalian central nervous system. While it mediates excitotoxic death triggered by
stroke and other acute trauma, there is growing evidence that physiological levels of NMDA
receptor activity promote survival. Understanding the mechanisms that underlie these opposing
effects may lead to strategies to selectively block pro-death signalling, which could have
considerable clinical benefits.
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Introduction
N-Methyl-D-Aspartate receptors (NMDARs) are cation channels, gated by glutamate, the
main excitatory neurotransmitter in the mammalian central nervous system (CNS). As well
as passing Na+, NMDARs also pass Ca2+, which mediates most of the physiological
consequences of NMDAR activity. NMDARs are found at the synapse, but also at
extrasynaptic locations, where their physiological role is ill-defined. NMDARs are essential
mediators of synaptic plasticity, as well as mediating aspects of development and synaptic
transmission. However, NMDARs cause cell death in many neuropathological scenarios
when excessively activated. Disturbance of extracellular glutamate levels, acting on
NMDARs, is a primary cause of neuronal death following acute trauma such as stroke,
mechanical trauma, and seizure [1].
NMDAR-dependent survival signalling
In contrast to the deleterious effects of excessive NMDAR activity, physiological patterns of
synaptic NMDAR activity actually promote neuronal survival. Elimination of NMDAR
activity in vivo causes widespread apoptosis in the developing CNS, exacerbates ongoing
neurodegeneration [2], and blocks ischemic preconditioning. The pro-survival effects of
NMDAR activity have been recapitulated in neuronal cultures as well [3, 4], enabling
scientists to study the signalling events responsible. Key among them is the PI3K-Akt
cascade, strongly activated by NMDARs in many, but not all neuronal types [4]. The PI3K-
Akt pathway can evoke neuroprotection via several routes, including phosphorylating/
inactivating both glycogen synthase kinase-3β, and the pro-apoptotic bcl-2 family member
BAD [5]. Akt also phosphorylates and triggers nuclear export of the FOXO subfamily of
forkhead transcription factors, which control the expression of pro-death genes such as
FasL, and Bim [5]. Stimulation of NMDAR signalling promotes PI3K-dependent FOXO
export and GSK3-beta phosphorylation, while GSK3-beta inhibitors can mimic the
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neuroprotective effect of low levels of NMDA [6]. Synaptic NMDAR signalling also
activates the Ras-ERK1/2 cascade [7] , with pro-survival consequences which including
CREB activation [7], BAD inactivation, and antagonizing GSK3β-induced apoptosis [4].
Synaptic NMDAR-dependent Ca2+ transients trigger a number of transcriptional changes
which mediates long-lasting neuroprotection [10]. An important mediator of activity-
dependent gene expression is the transcription factor, cAMP response element (CRE)
binding protein (CREB) [8]. Synaptic NMDAR activity induces CRE-dependent gene
expression [9] by a mechanism discussed elsewhere [3], and is causally linked to the long-
lasting phase of activity-dependent neuroprotection [10]. Induction of this long-lasting phase
requires Ca2+ transients to invade the nucleus, consistent with the known role for nuclear
Ca2+ in CREB activation via CaM Kinase IV [3]. The identity of the CREB-regulated
gene(s) responsible for long-lasting protection against apoptosis is currently not well
understood. The large number of known CRE-containing genes make it unlikely that a
single gene is responsible. The upregulation of CREB targets involved in responses to
oxidative stress (e.g. Sod2) or in inhibiting apoptosis (e.g. Bcl2) are implicated, although the
pro-survival neurotrophin Bdnf is supported by the most evidence [4].
NMDAR-dependent cell death
Pathological activation of NMDARs, with consequent intracellular Ca2+ deregulation, is the
primary cause of neuronal death following acute excitotoxic trauma such as ischemia [1]. In
cultures, neurons respond to high levels of NMDAR activity by undergoing delayed Ca2+
deregulation which precedes and predicts excitotoxic cell death. There are several
fundamental mechanisms implicated in NMDAR-dependent cell death, including cleavage
of the the plasma membrane Na+/Ca2+ exchanger (NCX) by the Ca2+-dependent protease
calpain [11], and mitochondrial dysfunction brought about by excessive Ca2+ uptake
through the uniporter [12]. Furthermore, overactivation of the Ca2+-dependent nNOS by
NMDAR activity has toxic downstream effects, including p38 map kinase signalling,
mitochondrial dysfunction and TRPM channel activation [1].
What determines whether an episode of NMDAR activity is neuroprotective
or excitotoxic?
The simplest answer is the magnitude of activation (intensity or duration). Response of
neurons to NMDA or glutamate dose follows a bell-shaped curve ([3] and references
therein): while low levels are protective, higher levels are toxic. This fact implies that the
Ca2+ effectors of survival have considerably lower requirements for Ca2+ than the death
effectors. Thus, the [Ca2+] threshold for activating pro-survival signalling by PI3K, ERK1/2
and CaMKIV-CREB must be lower than that which triggers toxic levels of calpain
activation, mitochondrial uptake or NO production. This idea sits well with the known low
Ca2+ affinity of certain potential death effectors, such as m-calpain and the mitochondrial
uniporter. Indeed, when exposing cortical neurons to escalating levels of NMDA, only toxic
doses evoke sustained increases in mitochondrial Ca2+ and loss of mitochondrial membrane
potential [6].
In addition to stimulus intensity, receptor location may play a role. We showed that
extrasynaptic NMDAR activity promotes inactivation of CREB and early excitotoxic events
such as mitochondrial depolarisation [9]. In contrast, similar Ca2+ loads evoked via synaptic
NMDARs strongly activate CREB, do not disturb mitochondrial function, and are
neuroprotective [9]. Interestingly, extrasynaptic NMDARs are also coupled to inactivation
of the ERK1/2 pathway, antagonizing the activation mediated by synaptic NMDARs [13].
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Fig. 1 shows an overview of the various NMDAR-induced pro-death and pro-survival
signalling events.
CREB dephosphorylation by extrasynaptic NMDAR activity is generally dominant over
CREB activating signals [9], possibly by activating a CREB phosphatase such as PP1.
However, in neurons exposed to low, protecting doses of NMDA, synaptic NMDARs are
preferentially activated due to the NMDA causing a dramatic increase in action potential
firing [6]. This enhanced firing mediates the NMDA-induced pro-survival signalling to Akt,
ERK1/2 and CREB [6]. In contrast, higher, toxic doses of NMDA do not favour synaptic
NMDAR activation because they strongly suppress firing rates [6], due presumably to
chronic depolarisation. While chronic exposure of neurons to glutamate and activation of
extrasynaptic NMDARs is unlikely to occur under normal physiological conditions, it will
occur under pathological conditions such as brain injury, or during hypoxic/ischemic insults
where glutamate transporters operate in reverse]. Consistent with this, CREB
dephosphorylation has been observed in in vivo stroke [3].
Clinical implications and concluding remarks
The pro-survival role of physiological synaptic NMDAR signalling, particularly prominent
during CNS development, points to the dangers of NMDAR antagonism during this period
in humans, which extends to several years post-natal [2]. Many paediatric/obstetric
anaesthetics and anticonvulsants (in)directly reduce NMDAR activity, while the dangers of
in utero exposure to NMDAR-antagonistic recreational drugs such as ketamine,
phencyclidine and ethanol cannot be overstated [2].
In treating excitotoxic trauma such as stroke, trials of NMDAR antagonists have failed due
to poor tolerance and efficacy [14], likely due to inhibition of physiological NMDAR-
mediated processes such as plasticity and pro-survival signalling. It is becoming clear that
the optimal therapeutic strategy should be to block the excitotoxic consequences of
NMDAR activation, while sparing pro-survival signals. Thus, targeting of calpains or
nNOS, or specific uncoupling of the NMDAR from pro-death signalling cascades may prove
more effective than global antagonists [1, 15].
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Fig. 1. Pro-survival and-death signaling from the NMDA receptor (see text for details)
Note that pro-death signaling generally requires more intense activation of NMDARs than
pro-survival signalling. Also, the pathways marked with a * are favoured by extrasynaptic
NMDAR activation [3, 9]. Ψm denotes mitochondrial membrane potential.
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